Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State

ABSTRACT Viral emergence and reemergence underscore the importance of developing efficacious, broad-spectrum antivirals. Here, we report the discovery of tetrahydrobenzothiazole-based compound 1, a novel, broad-spectrum antiviral lead that was optimized from a hit compound derived from a cytopathic effect (CPE)-based antiviral screen using Venezuelan equine encephalitis virus. Compound 1 showed antiviral activity against a broad range of RNA viruses, including alphaviruses, flaviviruses, influenza virus, and ebolavirus. Mechanism-of-action studies with metabolomics and molecular approaches revealed that the compound inhibits host pyrimidine synthesis and establishes an antiviral state by inducing a variety of interferon-stimulated genes (ISGs). Notably, the induction of the ISGs by compound 1 was independent of the production of type 1 interferons. The antiviral activity of compound 1 was cell type dependent with a robust effect observed in human cell lines and no observed antiviral effect in mouse cell lines. Herein, we disclose tetrahydrobenzothiazole compound 1 as a novel lead for the development of a broad-spectrum, antiviral therapeutic and as a molecular probe to study the mechanism of the induction of ISGs that are independent of type 1 interferons.

[1]  D. Chung.  The Establishment of an Antiviral State by Pyrimidine Synthesis Inhibitor is Cell Type-Specific , 2015, Journal of antimicrobial agents.

[2]  W. Chiu,et al.  An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. , 2015, Cell reports.

[3]  Yen-Liang Chen,et al.  Synergistic Suppression of Dengue Virus Replication Using a Combination of Nucleoside Analogs and Nucleoside Synthesis Inhibitors , 2015, Antimicrobial Agents and Chemotherapy.

[4]  Jennifer E. Golden,et al.  Development of (E)-2-((1,4-Dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-Amidinophenylbenzamides as Potent Inhibitors of Venezuelan Equine Encephalitis Virus , 2014, Journal of medicinal chemistry.

[5]  Jonathan L. Schmid-Burgk,et al.  Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. , 2014, Immunity.

[6]  Jennifer E. Golden,et al.  Discovery of a Novel Compound with Anti-Venezuelan Equine Encephalitis Virus Activity That Targets the Nonstructural Protein 2 , 2014, PLoS pathogens.

[7]  C. Stedman,et al.  Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential , 2014, Therapeutic advances in gastroenterology.

[8]  P. Vidalain,et al.  Inhibition of Pyrimidine Biosynthesis Pathway Suppresses Viral Growth through Innate Immunity , 2013, PLoS pathogens.

[9]  Imhoi Koo,et al.  MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics , 2013, Bioinform..

[10]  Jiyuan Zhang,et al.  Sofosbuvir and ABT-450: terminator of hepatitis C virus? , 2013, World journal of gastroenterology.

[11]  R. Kuo,et al.  MDA5 Plays a Crucial Role in Enterovirus 71 RNA-Mediated IRF3 Activation , 2013, PloS one.

[12]  K. Moon,et al.  Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation , 2013, Pediatric transplantation.

[13]  D. Smee,et al.  D282, a Non-Nucleoside Inhibitor of Influenza Virus Infection that Interferes with de novo Pyrimidine Biosynthesis , 2012, Antiviral chemistry & chemotherapy.

[14]  L. Kramer,et al.  Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis , 2011, Journal of Virology.

[15]  John A. Tallarico,et al.  Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) , 2011, Proceedings of the National Academy of Sciences.

[16]  D. Knight,et al.  Inhibition of Respiratory Syncytial Virus In Vitro and In Vivo by the Immunosuppressive Agent Leflunomide , 2011, Antiviral therapy.

[17]  V. Simon,et al.  Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis , 2011, Proceedings of the National Academy of Sciences.

[18]  D. Smee,et al.  T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture , 2010, Antimicrobial Agents and Chemotherapy.

[19]  P. Shi,et al.  Characterization of Dengue Virus Resistance to Brequinar in Cell Culture , 2010, Antimicrobial Agents and Chemotherapy.

[20]  Rashmi Kumar,et al.  Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  C. Goldsmith,et al.  Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. , 2005, Virology.

[22]  B. Hjelle,et al.  Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  S. Briolant,et al.  In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. , 2004, Antiviral research.

[24]  Y. Durocher,et al.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. , 2002, Nucleic acids research.

[25]  R. Johnston,et al.  Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. , 2000, Virology.

[26]  T. Traut,et al.  Intrinsic Activity and Stability of Bifunctional Human UMP Synthase and Its Two Separate Catalytic Domains, Orotate Phosphoribosyltransferase and Orotidine-5′-phosphate Decarboxylase (*) , 1996, The Journal of Biological Chemistry.

[27]  J. Rowley,et al.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. K. Robins,et al.  Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide , 1972, Science.

[29]  P. Vidalain,et al.  Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors. , 2016, Antiviral research.

[30]  S. Akira,et al.  Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. , 2009, The Journal of general virology.

[31]  James W. Williams,et al.  Leflunomide in solid organ transplantation and polyoma virus infection. , 2006, Advances in experimental medicine and biology.